Health news

  1. Newly approved in the EU: Durvalumab (Imfinzi) an immunotherapy for Stage III Lung Cancer

    Read more »
  2. Where data and humanity meet: an algorithm to improve medicine pricing models

    Industry NewsHow two professors imagine a better world for stakeholders in the medical industry. 

    Read more »
  3. CAR T cell approval may offer patients a new form of therapy

    Industry NewsAccording to study investigators, about a third of patients could benefit from this therapy that may offer remissions, relieve symptoms and save lives.

    Read more »
  4. PRESS RELEASE: ALS İÇİN YENİ TEDAVİLER UMUT OLUYOR

    Turkish Press Release

    Read more »
  5. Kisqali (ribociclib) approved for additional indications in HR+/HER2- advanced breast cancer

    News updateKisqali is now the only CDK4/6 inhibitor for use with an aromatase inhibitor for the treatment of pre-, peri- or postmenopausal women in the US.

    Read more »
  6. 2018 - Good year for new FDA approvals of cancer treatments

    2018 has been a good year for new cancer treatments says the U.S. AACR. 
    AACR news 

    Read more »
  7. Erenumab (Aimovig) now approved for the European Union

    The new preventive medicine for migraine Aimovig (erenumab) has been approved by the EMA. Read more...
    Breaking News 

    Read more »
  8. 10 important facts to know about the new migraine injection

    You might have heard about a new medicine that’s just been approved to treat migraine. Here’s what you need to know.

    Glasses

    Read more »
  9. A new answer for treating migraines?

    7 need-to-knows about migraine as well as some updates on the latest treatment developments

    Blog post

    Read more »
  10. New relief for migraine patients?

    News updateThe first-ever preventative treatment for migraine in adults, Aimovig (erenumab-aooe) is now approved by the Food and Drug Administration.

    Read more »
Posts loader